Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04461600
Title A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer (TENACITY)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ayala Pharmaceuticals, Inc,
Indications

triple-receptor negative breast cancer

Therapies

BMS-906024

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.